Drug Shortage Report for GABAPENTIN
| Report ID | 24913 |
| Drug Identification Number | 02353261 |
| Brand name | GABAPENTIN |
| Common or Proper name | GABAPENTIN CAPS |
| Company Name | SANIS HEALTH INC |
| Market Status | MARKETED |
| Active Ingredient(s) | GABAPENTIN |
| Strength(s) | 400MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 500 |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2017-10-16 |
| Actual start date | |
| Estimated end date | 2017-11-10 |
| Actual end date | 2017-10-26 |
| Shortage status | Resolved |
| Updated date | 2017-10-27 |
| Company comments | Delay in release of replenishment batch |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2017-10-27 | English | Compare |
| v6 | 2017-10-26 | French | Compare |
| v5 | 2017-10-26 | English | Compare |
| v4 | 2017-10-17 | English | Compare |
| v3 | 2017-10-10 | French | Compare |
| v2 | 2017-10-10 | English | Compare |
| v1 | 2017-10-10 | English | Compare |
Showing 1 to 7 of 7